In vitro assessment of the cytotoxicity of anti-allergic eye drops using 5 cultured corneal and conjunctival cell lines

Journal of Oleo Science

Volumn 60, Issue 3, 2011, Pages 139-144

  Ayaki, Masahiko ^a   Iwasawa, Atsuo ^b   Yaguchi, Shigeo ^c   Koide, Ryohei ^c  

^a SAITAMA NATIONAL HOSPITAL   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Benzalkonium chloride; Cell viability score; Eye; Eye drop; Preservative; Toxicity

Indexed keywords

CATIONIC SURFACTANTS; CELL CULTURE; CHLORINE COMPOUNDS; CYTOLOGY; DROPS; ENDOTHELIAL CELLS; TOXICITY;

ACTIVE COMPONENTS; BENZALKONIUM CHLORIDE; CELL VIABILITY SCORES; CONCENTRATION-DEPENDENT; CORNEAL EPITHELIAL CELLS; CORNEAL EPITHELIUM; EYE DROPS; PRESERVATIVE;

CELLS;

EID: 79951805309     PISSN: 13458957     EISSN: 13473352     Source Type: Journal    
DOI: 10.5650/jos.60.139     Document Type: Article

References (20)

1. Baudouin, C. Allergic reaction to topical eyedrops. Curr. Opin. Allergy Clin. Immunol. 5, 459-463 (2005)
2. Baudouin, C.; Labbé, A.; Liang, H.; Pauly, A.; Brignole- Baudouin, F. Preservatives in eyedrops: The good, the bad and the ugly. Prog. Retin. Eye. Res. 29, 312-334 (2010)
3. Ayaki, M.; Taguchi, Y.; Soda, M.; Yaguchi, S.; Iwasawa, A.; Koide, R. Preserved and unpreserved 12 anti-aller- gic ophthalmic solutions and ocular surface toxicity: In vitro assessment in four cultured corneal and conjunc- tival epithelial cell lines. Biocontrol Sci. in press
4. Ayaki, M.; Yaguchi, S.; Koide, R.; Iwasawa, A. Human corneal endothelial toxicity of eye drop with and with- out preservatives. Exp. Clin. Ophthalmol. 36, 553-559 (2008)
5. Ishiyama, M.; Shiga, M.; Sasamoto, K.; Mizoguchi, M.;, He, P. A new sulfonated tetrazolium salt that produces a highly water-soluble formazan dye. Chem. Pharm. Bull. 41, 1118-1122 (1993).
6. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-63 (1983)
7. Ayaki, M.; Soda, M.; Yaguchi, S.; Iwasawa, A.; Koide, R. Cytotoxicity of five fluoroquinolone and two non- steroidal anti-inflammatory benzalkonium chloride- free eye drops in four corneoconjunctival cell lines. Clinical Ophthalmol. 4, 1019-102 (2010).
8. Ayaki, M.; Iwasawa, A.; Yaguchi, S.; Koide, R. Pre- served and unpreserved 12 anti-allergic eye drops and ocular surface toxicity: in vitro assessment in four cultured corneal and conjunctival epithelial cell lines. Biocontrol Sci. 15, 97-10 (2010)
9. Ayaki, M.; Iwasawa, A. Cytotoxicity of prostaglandin analogue eye drops preserved with benzalkonium chloride in multiple corneoconjunctival cell lines. Clinical Ophthalmol. 4, 919-924 (2010)
10. Ayaki, M.; Iwasawa, A.; Inoue, Y. Toxicity of antiglau- coma drugs with and without benzalkonium chloride to cultured human corneal endothelial cells. Clinical Ophthalmol. 4, 1217-122 (2010)
11. Nakashima, M.; Nakamura, T.; Teshima, M.; To, H.; Ue- matsu, M.; Kitaoka, T.; Taniyama, K.; Nishida, K.; Na- kamura, J.; Sasaki, H. Breakdown evaluation of corneal epithelial barrier caused by antiallergic eyedrops using an electrophysiologic method. J. Ocul. Pharmacol. Ther. 24, 43-51 (2008).
12. Oshima, T.; Kurosaka, D.; Kato, K.; Kurosaka, H.; Mashima, Y.; Tanaka, Y.; Tajima, S. Tranilast inhibits cell proliferation and collagen synthesis by rabbit cor- neal and Tenon&s capsule fibroblasts. Curr. Eye Res. 20, 283-286 (2000)
13. Lekhanont, K.; Park, C.Y.; Combs, J.C.; Suwan-Api- chon, O.; Rangsin, R.; Chuck, R.S. Effect of topical olopatadine and epinastine in the botulinum toxin B-induced mouse model of dry eye. Ocul. Pharmacol. Ther. 23, 83-88 (2007).
14. Dogru, M.; Ozmen, A.; Ertürk, H.; Sanli, O.; Karatas, A. Changes in tear function and the ocular surface after topical olopatadine treatment for allergic conjunctivi- tis: An open-label study. Clin. Ther. 24, 1309-1321 (2002)
15. Tominaga, Y.; Nakamura, Y.; Tsuji, K.; Shibata, T.; Kata- oka, K. Ibudilast protects against neuronal damage in- duced by glutamate in cultured hippocampal neurons. Clin. Exp. Pharmacol. Physiol. 23, 519-523 (1996)
16. Barkhof, F.; Hulst, H.E.; Drulovic, J.; Uitdehaag, B.M.; Matsuda, K.; Landin, R.; MN166-001 Investigators. Ibu- dilast in relapsing-remitting multiple sclerosis: a neuroprotectant? Neurol. 74, 1033-1040 (2010).
17. Tanaka, M.; Dogru, M.; Takano, Y.; Miyake-Kawashima, M.; Asano-Kato, N.; Fukagawa, K.; Tsubota, K.; Fu- jishima, H. The relation of conjunctival and corneal findings in severe ocular allergies. Cornea 23, 464-467 (2004).
18. Fukuda, M.; Takahashi, N. Intraocular penetration of gatifloxacin eye drop in rabbit eye - Calculation of maximum aqueous concentration (AQCmax). Ata- rashii Ganka 21, 1109-1112 (2004).
19. Fukuda, M.; Sasaki, H.; Ohashi, Y. Intraocular penetra- tion of moxifloxacin eye drop in rabbit eye - Calcula- tion of maximum drug concentration in aqueous con- centration (AQCmax) Atarashii Ganka 23, 1353- 1357 (2006).
20. Ellis, P.P.; Pfoff, D.S.; Bloedow, D.C.; Riegel, M. Intra- ocular diclofenac and flurbiprofen concentrations in human aqueous humor following topical application. Ocul. Pharmacol. 10, 677-682 (1994)